Bio


Dr. Skylar-Scott is a board-certified, fellowship-trained cognitive and behavioral neurologist and clinical assistant professor at Stanford University.

Her clinical interests include the treatment of cognitive and behavioral impairment due to Alzheimer’s disease, Parkinson’s disease, Lewy body dementia, posterior cortical atrophy, primary progressive aphasia, frontotemporal dementia, vascular dementia, primary age-related tauopathy, and limbic-predominant age-associated TDP-43 encephalopathy, among other disorders of cognition and behavior.

Her research interests include clinical trials for Alzheimer’s disease and how social and intellectual engagement can affect cognition. She also has investigated impaired consciousness in epilepsy and biomarkers for assessing Duchenne muscular dystrophy. Prior to joining Stanford, Dr. Skylar-Scott was a fellow in the Center for Alzheimer’s Research and Treatment (CART) in the Department of Neurology at Harvard Medical School/Brigham and Women’s Hospital.

Dr. Skylar-Scott’s work has appeared in Pediatric Neurology, the Journal of Ultrasound in Medicine, Muscle & Nerve, and Epilepsia. She also has co-written chapters on Alzheimer’s disease and normal pressure hydrocephalus in Ferri’s Clinical Advisor: Instant Diagnosis and Treatment. She has written a forthcoming chapter on Parkinson’s disease dementia and Lewy body dementia as well as a chapter on neuroimmunological disorders to be published by McGraw-Hill.

Presentations by Dr. Skylar-Scott have focused on prevention of cognitive decline in at-risk elderly people, cognitive and neuropsychiatric manifestations of Parkinson’s disease, human prion diseases, and other topics. She has presented at meetings held by the American Academy of Neurology (AAN), the American Neurological Association (ANA), and the American Academy of Neuromuscular and Electrodiagnostic Medicine (AANEM).

For her research and scholarship, Dr. Skylar-Scott has earned honors from the American Academy of Neurology (AAN) and the Howard Hughes Medical Institute (HHMI). She was honored to receive the Golseth Young Investigator Award from the American Association of Neuromuscular & Electrodiagnostic Medicine. In addition, she won the Action Duchenne International Conference First Prize Poster for her research in Duchenne muscular dystrophy.

Dr. Skylar-Scott is a member of the American Neurological Association and American Academy of Neurology. Her community service focuses on reducing hunger and homelessness. She also received a grant to establish tuberculosis community support groups in New Delhi, India.

Clinical Focus


  • Neurology

Academic Appointments


Professional Education


  • Fellowship: Brigham and Women's Hospital Neurology Fellowship (2020) MA
  • Board Certification: American Board of Psychiatry and Neurology, Neurology (2018)
  • Residency: Beth Israel Deaconess Medical Center Neurology Residency (2018) MA
  • Internship: Yale New Haven Medical Center Transitional Year (2015) CT
  • Medical Education: Yale School Of Medicine Office of Student Affairs (2014) CT